AJMC® in the Press, May 1, 2026

Why It Matters

Relying on under‑resourced local labs could delay critical treatments and strain public‑health capacity, affecting both human and animal health outcomes.

Key Takeaways

• CDC halts mpox, rabies testing amid lab restructuring
• State labs now responsible for initial diagnostic confirmation
• Potential delays in post‑exposure prophylaxis treatments
• Louisiana wildlife surveillance gains heightened importance
• Local public‑health capacity may be stretched thin

Pulse Analysis

The Centers for Disease Control and Prevention announced a sweeping restructuring of its national reference laboratories, citing budgetary pressures and a strategic shift toward decentralized testing. As part of the plan, routine diagnostic assays for emerging pathogens such as mpox and long‑standing threats like rabies have been placed on hold. The move reflects a broader federal trend of consolidating core functions while expecting state and local health departments to absorb more operational responsibilities. Analysts warn that the abrupt cessation of centralized testing could create gaps in surveillance at a time when zoonotic spillovers remain a global concern.

With the CDC’s pause, state and municipal laboratories are now the first line for confirming suspected mpox or rabies cases. Many of these agencies lack the high‑throughput platforms and biosafety infrastructure that the federal labs provide, forcing them to reallocate limited staff and equipment. In regions such as Louisiana, where bats and skunks serve as primary rabies reservoirs, any lag in confirming infection can postpone post‑exposure prophylaxis, increasing morbidity risk. Veterinary clinics and emergency departments are already reporting longer turnaround times, prompting calls for emergency funding and rapid training programs.

The ripple effects extend beyond human health to veterinary practice and wildlife management. Enhanced local surveillance becomes essential, requiring coordinated reporting between animal control, hunters, and public‑health officials. Policymakers are weighing options ranging from temporary federal contracts with private labs to the creation of regional testing hubs that can share resources across state lines. While the CDC’s restructuring aims to modernize the public‑health laboratory network, the transition underscores the delicate balance between cost containment and maintaining a resilient diagnostic capacity capable of responding to emerging infectious threats.